32 related articles for article (PubMed ID: 11364365)
1. Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.
Ou W; Silver J
Retrovirology; 2005 Aug; 2():51. PubMed ID: 16092970
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.
Bower JF; Li Y; Wyatt R; Ross TM
Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193
[TBL] [Abstract][Full Text] [Related]
3. Maturation inhibitors: a new therapeutic class targets the virus structure.
Salzwedel K; Martin DE; Sakalian M
AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941
[TBL] [Abstract][Full Text] [Related]
4. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
5. HIV eradication theory meets reality.
TreatmentUpdate; 1999 May; 11(3):3. PubMed ID: 11366779
[TBL] [Abstract][Full Text] [Related]
6. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
[TBL] [Abstract][Full Text] [Related]
7. The effect of HAART on humoral immune response in primary HIV-1 infected patients.
Pastori C; Barassi C; Lillo F; Longhi R; Capiluppi B; Nozza S; Galli A; Uberti-Foppa C; Lazzarin A; Tambussi G; Lopalco L
J Biol Regul Homeost Agents; 2002; 16(1):9-17. PubMed ID: 12003182
[TBL] [Abstract][Full Text] [Related]
8. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
McBurney SP; Young KR; Ross TM
Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization studies of an antisense protein in HIV-1-infected cells and viral particles.
Briquet S; Vaquero C
Virology; 2002 Jan; 292(2):177-84. PubMed ID: 11878921
[TBL] [Abstract][Full Text] [Related]
10. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
11. Protein discovery may open new topics.
AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364365
[TBL] [Abstract][Full Text] [Related]
12. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
13. Antiviral properties of two trimeric recombinant gp41 proteins.
Delcroix-Genête D; Quan PL; Roger MG; Hazan U; Nisole S; Rousseau C
Retrovirology; 2006 Mar; 3():16. PubMed ID: 16515685
[TBL] [Abstract][Full Text] [Related]
14. Deletion of the vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced Env precursor synthesis but is less pathogenic for pig-tailed macaques.
Stephens EB; McCormick C; Pacyniak E; Griffin D; Pinson DM; Sun F; Nothnick W; Wong SW; Gunderson R; Berman NE; Singh DK
Virology; 2002 Feb; 293(2):252-61. PubMed ID: 11886245
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
